Matrix stiffness-related extracellular matrix signatures and the DYNLL1 protein promote hepatocellular carcinoma progression through the Wnt/β-catenin pathway
Abstract Background In hepatocellular carcinoma (HCC) treatment, first-line targeted therapy in combination with immune checkpoint inhibitors (ICIs) has improved patient prognosis, but the 5-year survival rate is far from satisfactory. Studies have shown that the extracellular matrix (ECM) is an ess...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMC
2024-09-01
|
| 叢編: | BMC Cancer |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1186/s12885-024-12973-5 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
